FOLH1 and central nervous system cancer: [68Ga]-PSMA–Glu–NH–CO–NH–Lys-2-naphthyl-L-Ala-cyclohexane-DOTA ([68Ga]Ga-PSMA-617) has a lower non-specific affinity to the kidneys compared to [68Ga]Ga-PSMA-11 [10], and preliminary clinical results show significantly high values of in vivo uptake into high grade gliomas [11].